|
|
Blood, 1 May 2005, Vol. 105, No. 9, pp. 3686-3690.
Prepublished online as a Blood First Edition Paper on December 30, 2004; DOI 10.1182/blood-2004-09-3782.
Previous Article | Next Article 
Submitted September 30, 2004
Accepted December 13, 2004
The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage
Paolo Salomoni, Rosa Bernardi, Stephan Bergmann, Austin Changou, Sara Tuttle, and Pier Paolo Pandolfi*
Cancer Biology and Genetics Program, Department of Pathology, Sloan-Kettering Institute, Weill Graduate School of Medical Sciences, Cornell University, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
* Corresponding author; email: p-pandolfi{at}ski.mskcc.org.
The promyelocytic leukemia (PML) gene, a tumor suppressor inactivated in acute promyelocytic leukemia (APL), regulates apoptosis induced by DNA damage. However, the molecular mechanisms by which PML modulates apoptosis following genotoxic stress are only partially elucidated. PML is essential for p53-dependent induction of programmed cell death upon -irradiation through PML-Nuclear Body (NB)-mediated control of p53 acetylation. Here we show that PML selectively regulates pro-apoptotic transcription factors upon different types of DNA damage. We find that Pml inactivation protects fibroblasts from UV-induced apoptosis in a p53-independent manner. We demonstrate that c-Jun is required for UV-induced apoptosis and that PML is essential for both c-Jun transcriptional activation and DNA binding upon UV. We find that PML physically interacts with c-Jun and that upon UV the PML-NBs reorganize into novel nuclear microspeckled structures (UV-NBs), where PML and c-Jun dynamically accumulate. These data identify a novel PML-dependent pathway for c-Jun transcriptional activation and induction of apoptosis in response to DNA damage and shed new light on the role of PML in tumor suppression.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
The ProMiscuousLy (PML) exciting nuclear protein has another partner
- Kirsten Jensen, Carol Shiels, and Paul S. Freemont
Blood 2005 105: 3393-3394.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
O. Yogev, S. Anzi, K. Inoue, and E. Shaulian
Induction of Transcriptionally Active Jun Proteins Regulates Drug-induced Senescence
J. Biol. Chem.,
November 10, 2006;
281(45):
34475 - 34483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. O. Boe, M. Haave, A. Jul-Larsen, A. Grudic, R. Bjerkvig, and P. E. Lonning
Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA
J. Cell Sci.,
August 15, 2006;
119(16):
3284 - 3295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bellodi, K. Kindle, F. Bernassola, D. Dinsdale, A. Cossarizza, G. Melino, D. Heery, and P. Salomoni
Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-{alpha}
J. Biol. Chem.,
May 19, 2006;
281(20):
14465 - 14473.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |